ARTICLE | Company News
Histogenics, ProChon Biotech deal
May 23, 2011 7:00 AM UTC
Histogenics acquired ProChon, a developer of fibroblast growth factor-based therapeutics, in a stock-for-stock merger. ProChon CEO Patrick O'Donnell was named CEO, president and a director of the comb...